NRXS NRXS
Company Profile ↓Company Overview
NRXS (NRXS) is a publicly traded company listed on with a market capitalization of $72.33M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.12.
Recent Developments
- Dec 2025 Revenue of $3.57M (+32.9% YoY); net profit $-7.80M.
- Trailing 12 Months Year-on-year growth — revenue +32.9%.
- 5-Year Trend Long-term compounding — revenue CAGR 10.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 9.96% |
| 1 Year: | 32.89% |
Stock Price Performance
| 1 Year: | +169.44% |
| 6 Months: | +61.28% |
| 3 Months: | -21.86% |
| 1 Month: | -4.77% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)49.75 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | 682.58K | 618.80K | 805.11K | 646.02K | 477.46K | 646.63K | 611.50K | 666.62K | - | 895.65K | 894.09K | 811.41K | 968.13K | 1.61M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | 139.47K | 146.64K | 135.49K | 141.65K | 218.37K |
| Gross Profit | - | 603.57K | 551.17K | 709.21K | 578.21K | 410.17K | 571.55K | 538.04K | 569.58K | - | 756.18K | 747.44K | 675.93K | 826.48K | 1.39M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | 3.05M | 2.47M | 2.78M | 2.54M | 3.13M |
| Operating Income | - | -669.58K | -1.20M | -896.27K | -1.12M | -3.02M | -1.83M | -2.21M | -1.65M | - | -2.30M | -1.72M | -2.10M | -1.72M | -1.74M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | -2.27M | -1.66M | -2.08M | -1.66M | -1.72M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | 2.24K | 13.43K | 29.66K | 28.64K | 26.19K |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | -2.28M | -1.69M | -2.12M | -1.71M | -1.76M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income | -1.17M | -1.52M | -2.08M | -2.17M | -2.24M | -8.63M | -2.12M | -2.92M | -1.76M | - | -2.28M | -1.69M | -2.12M | -1.71M | -1.76M |
| Diluted EPS | - | -0.87 | -1.14 | -1.18 | -1.21 | -2.38 | -0.32 | -0.42 | -0.25 | - | -0.33 | -0.22 | -0.24 | - | -0.18 |
| R&D Expense | - | 13.66K | 86.17K | 16.80K | 109.79K | 44.95K | 5.57K | 54.31K | 126.25K | - | 117.87K | 58.32K | 130.85K | - | 99.57K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 2.68M | 2.46M | 2.69M | 3.57M |
| Cost of Revenue | - | 297.06K | 303.35K | 362.00K | 562.92K |
| Gross Profit | - | 2.39M | 2.16M | 2.32M | 3.01M |
| Operating Expenses | - | 5.76M | 8.82M | 9.48M | 10.84M |
| Operating Income | - | -3.37M | -6.66M | -7.16M | -7.83M |
| EBITDA | - | -4.33M | -9.23M | -7.90M | -7.67M |
| Interest Expense | - | 417.60K | 5.36M | 300.71K | 73.97K |
| Pretax Income | - | -4.78M | -14.63M | -8.24M | -7.80M |
| Tax Provision | - | - | - | - | - |
| Net Income | - | -4.78M | -14.63M | -8.24M | -7.80M |
| Diluted EPS | - | -0.90 | -2.25 | -1.22 | -0.95 |
| R&D Expense | - | 225.61K | 169.31K | 433.61K | 493.61K |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Sep 2023 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Total Assets | - | 1.48M | 1.24M | 509.50K | 4.76M | 6.40M |
| Current Assets | - | 476.96K | - | 242.61K | 4.27M | 5.73M |
| Cash & Equivalents | - | 253.70K | 761.25K | 78.56K | 3.70M | 4.97M |
| Inventory | - | 48.13K | - | 21.22K | 44.33K | 257.13K |
| Receivables | - | 174.40K | - | 73.17K | 244.62K | 195.70K |
| Total Liabilities | - | 7.05M | 2.30M | 1.91M | 2.69M | 3.00M |
| Current Liabilities | - | 6.98M | 2.26M | 1.89M | 2.43M | 2.79M |
| Long Term Debt | 51.69K | - | - | - | - | - |
| Total Debt | - | 598.82K | - | 224.26K | 473.40K | 416.61K |
| Total Equity | - | -5.57M | -1.06M | -1.40M | 2.07M | 3.40M |
| Shares Outstanding | - | 6.04M | - | 6.51M | 6.99M | 10.65M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -2.30M | -6.69M | -6.10M | -6.43M |
| Investing Cash Flow | - | -61.20K | -71.78K | -27.78K | -131.15K |
| Financing Cash Flow | - | 2.29M | 6.59M | 9.74M | 7.83M |
| Capital Expenditure | - | -61.20K | -71.78K | -27.78K | -131.15K |
| Free Cash Flow | - | -2.36M | -6.77M | -6.13M | -6.56M |
| Net Change in Cash | - | -67.16K | -175.14K | 3.62M | 1.27M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 88.9% | 87.7% | 86.5% | 84.2% |
| Operating Margin % | - | -125.6% | -270.9% | -266.5% | -219.4% |
| Net Margin % | - | -178.0% | -594.6% | -306.8% | -218.5% |
| ROE % | - | 85.8% | 1,042.4% | -398.6% | -229.5% |
| ROCE % | - | 61.3% | 484.3% | -307.9% | -216.8% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NRXS
NeurAxis, Inc. to Report Second Quarter 2026 Financial Results on August 11 and Host Conference Call - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxOb3VfV1N4WVAxRjV2MmdBRGluTWV6TE5tRUJNanNOWllmMF9nY0pvekczUXV4VzdUb1BjVVhFby01NXJwSktrZDRSaUk2R2tERno0elkzUmxpZE1vUXVnS2RRdXVjb3paNC1jTTd4em9CRGdublRyMXZuQm04Ylk3S1dzVExFaTBLeEN4Yn…
NRXS Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE4wRk9SMVg1VjlSdVBkOW5jaWkxYkRZX0Z0bkpjbFVIMFBUUDlwVlVIWHFoWmtFUGV2ZHRHWUdUeDkwMnZfOTRJVFl6NGZCRXh4Qkd0dkxvdk9jWmNkSUlmT3I4eWh5dmJaQS1naVZPT1k1OGowZFln?oc=5" target="_blank">NRXS Fo…
NRXS|Neuraxis Inc|Price:6.590|Chg%:+0.340 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTFAxLTkyV1JrMC1aWUZlS1ZjYzNTSWFvUWFFYkx2YXJCZVlzMF9VQjNqNF9lV0NnUWl3QXFDUXJjUER4ZUxaNVUtdkdyaUVwd1JFU2RUMm9GTjUzcGR6ODdQREVWNjlGaDBaU0xVWHd3?oc=5" target="_blank">NRXS|Neuraxis Inc|P…
NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth - GlobeNewswire
<a href="https://news.google.com/rss/articles/CBMihgJBVV95cUxOX3g0bkZ2Z3psTENuaGtWX1lNQzhMa1gxS0lFUHF1NEZmMU5yZXN3V3Q1UjZLVHhKTzI2bFlKQXVMcmdyZW12TGM2N1YtaEZDVWR4bzJQNXNfNmVQYjczZXZhNGhLS28zTG1zMjNDU2NHcUkwTVRzQy10UGltemlDR0pvczh5S3VSS0VoT0…
NeurAxis Stock Gains Post Q1 Earnings, Revenues and Margin Surge Y/Y - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxNeG53TXJITE8wRDBjZnJBSVlqWXJxdDZHQ1N4VVZndjdVLVR4S0NGdUdaV1JJRXVRU180SFVrRUtaemc2RGtNX3NXOFFsVE5uYUFvclVMVDN2S1d6eDNZampZbmRyMW1kRlFzZEtHT0FMMmpsMmhUY0NRdDFIZEs3YkJHdk9nOUhhXzl6bX…
NRXS|Neuraxis Inc|Price:6.735|Chg%:+0.485 - TradingKey
<a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE84bmpYNFJ2ZHNTSWlLSEQzNDdNTVZpS0V6bnpWaXNoVWY0Z2xpVjdmS21SRVVXZDZCSmZLdXhERDVPLURLdXR6SXk3OXNTVXhwb3E3elh0TC1YZ0Y5TUFER3FFd3I?oc=5" target="_blank">NRXS|Neuraxis Inc|Price:6.735|Ch…
NRXS — Frequently Asked Questions
What is the current share price of NRXS?
As of 2026-08-05 17:25 PDT, NRXS trades at $6.79 on NASDAQ/NYSE. Its 52-week range is $2.31 to $8.81.
What is the market capitalisation of NRXS?
NRXS has a market capitalisation of $72.33M on NASDAQ/NYSE.
What is the P/E ratio of NRXS?
NRXS trades at a trailing price-to-earnings (P/E) ratio of -7.15. Its price-to-book (P/B) ratio is 21.28.
Is NRXS a good stock to buy?
This page provides a data-driven analysis of NRXS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.